EXAGEN INC. — Director's Dealing 2019

Sep 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2019-09-18

Reporting Person: Elliott Jeffrey Thomas (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-18	Stock Option (right to buy)	$14.00	A	13613	Acquired	2029-09-17	Common Stock (13613)	Direct

Footnotes

F1: The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on October 18, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date.